Advertisement

Topics

Pamplona to buy US firm Parexel International for $5bn

00:57 EDT 21 Jun 2017 | Pharmaceutical Business Review

Pamplona Capital Management has agreed to acquire US-based biopharmaceutical services provider Parexel International for around $5bn.

Original Article: Pamplona to buy US firm Parexel International for $5bn

NEXT ARTICLE

More From BioPortfolio on "Pamplona to buy US firm Parexel International for $5bn"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...